Dupuytren Research Group - Dupuytren Foundation Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Dupuytren Research Group - Dupuytren Foundation's estimated annual revenue is currently $2.8M per year.(i)
  • Dupuytren Research Group - Dupuytren Foundation's estimated revenue per employee is $162,000

Employee Data

  • Dupuytren Research Group - Dupuytren Foundation has 17 Employees.(i)
  • Dupuytren Research Group - Dupuytren Foundation grew their employee count by 6% last year.

Dupuytren Research Group - Dupuytren Foundation's People

NameTitleEmail/Phone
1
Founder and Executive DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.4M390%N/AN/A
#2
$15.3M63-9%N/AN/A
#3
$8.4M398%N/AN/A
#4
$9.9M46-2%N/AN/A
#5
$9.7M457%N/AN/A
#6
$23.8M88-3%N/AN/A
#7
$8.9M4114%N/AN/A
#8
$526.9M13943%N/AN/A
#9
$10.2M47-6%N/AN/A
#10
$7.8M366%N/AN/A
Add Company

What Is Dupuytren Research Group - Dupuytren Foundation?

WHAT WE DO: The Dupuytren Foundation is a 501(c)3 Public charity working to find a cure for Dupuytren's Disease and related conditions. HOW WE DO IT: We provide educational resources (patient brochures, conference presentations, academic publications) and have organized the largest Dupuytren research study ever undertaken: the International Dupuytren Data Bank (IDDB). The IDDB was designed from the ground up with the goal of developing a cure for Dupuytren disease. WHY THIS MATTERS: Dupuytren disease is not just a hand deformity: it has profound effects on overall health and lifespan in the millions of people it affects. Compared to the average population, people with Dupuytren contracture have twice the risk of cancer, and have shortened lifespans from cancer and other medical conditions. A medical treatment of Dupuytren disease will impact overall health far beyond the benefit to people's hands. We are the only independent group working for a cure rather than focusing entirely on finger deformity. This is a fundamental shift in thinking, and the biggest step forward since this condition was named after Dupuytren, the surgeon. We don't need a better operation: we need a cure.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.8M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Dupuytren Research Group - Dupuytren Foundation News

2022-04-13 - Galderma's 'Rosacea Space' provides creative outlet for ...

The independent dermatology company was spun out in 2019 from a wholly owned ... Endo is banking on established Dupuytren's contracture med Xiaflex and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M17N/AN/A
#2
$1.5M17-32%N/A
#3
$2.8M17-47%N/A
#4
$4.5M186%N/A
#5
$2.7M18-28%N/A